Indian pharma poised for Robust Growth, Likely to Benefit from Biosecure Act: Experts Speaking at the inaugural panel discussion at the ETPharma Tech Innovate Conclave, top industry experts highlighted that innovations such as #AI, #automation, and digital tools will play a critical role in optimising #manufacturing processes, improving drug efficacy and quality, and simplifying drug administration techniques. Experts also emphasized that, contrary to popular belief, the U.S. #Biosecure_Act is likely to benefit India in the long run and will open significant #opportunities for Indian companies. #Automation | #PharmaFuture | #LeanManufacturing | #PatientCentricity | #PrecisionMedicine I Dr. Sanjeev Panchal | AstraZeneca India | Achin Gupta | Cipla | Amrut Medhekar | shirish belapure | Vikas Dandekar | Prathiba Raju I Akums Drugs& Pharmaceuticals Ltd I Indian Pharmaceutical Alliance Read more: https://lnkd.in/eXWfxtqy
